When is it okay to ask for a referral?

After you've created value or at least a real relationship. Right after a first meeting is usually too soon unless they offered. A good test: would they be slightly proud to put you in front of a peer? Name the stall they care about, offer one small next step, and stop before the thread feels like a sequence.

Do founders actually read cold email?

Some do, usually the ones that feel written to their company this week. If you cite a real trigger and keep the ask small, you have a chance. If you mail-merge 'loved your journey,' you don't. Name the stall they care about, offer one small next step, and stop before the thread feels like a sequence.

What subject line works for Pharmaceuticals referral request emails (after a demo)?

Name the situation and the business object, not your excitement. Something like "Quick referral ask on [topic]" outperforms "Just checking in" because a founder can decide from the preview text whether it's worth opening. Keep it under 50 characters when you can.

How many times should I follow up with a Founder (after a demo)?

Ask after you've given them a reason to want to help, not after the first coffee. Same day with the recap. A value bump 3 days later if they went quiet. After that, send a breakup note and archive it. A founder who wants it will answer a clean close more often than a fifth bump.

Should I offer a referral fee in the email?

Only if that's already how you work and it won't make them look mercenary. Many operators prefer a clean intro. If you do mention a fee, keep it secondary to why the intro helps the other person. Name the stall they care about, offer one small next step, and stop before the thread feels like a sequence.

Pharmaceuticals · Founder · After Demo

Referral Request for Pharmaceuticals Founder: After Demo

The query is practical: what should a referral request email to a Pharmaceuticals Founder say for after a demo? Start with a direct answer, add one proof point about follow-up that ignores MLR, off-label risk, and the fact that 'just a quick claim' isn't quick, and close with ask who else needs to see it, or whether a narrower use

Last updated: 2026-09-02 · Reviewed by: Sales Email Template editors

We write templates the way we wrote emails on quota: short, specific, and easy to forward. When we cite research below, it is because the number changes how a buyer reads your note, not to pad the page.

Sources: HubSpot sales email benchmarks; Gong follow-up research

Why does this referral request work for a Pharmaceuticals Founder?

Give them cover to decline.
Speaks to follow-up that ignores MLR, off-label risk, and the fact that 'just a quick claim' isn't quick instead of a generic "value prop."
Fits how a founder actually reads: Short, vivid, one proof point max.
Replay the two moments they leaned in, and the one concern they named.
Ask for a specific profile, not 'anyone in your network.'

When should I send this to a Pharmaceuticals Founder?

Ask after you've given them a reason to want to help, not after the first coffee. Same day with the recap. A value bump 3 days later if they went quiet. For this combo, treat "Same day, then 3 days if silent" as the default, then adjust around launch calendars and review boards set speed. you don't. If you're emailing a founder, Short, vivid, one proof point max. If they named a board week or a freeze, believe it and leave a reopen date.

What this Founder actually cares about

A founder in Pharmaceuticals is protecting runway, focus, and the company's early reputation. They context-switch constantly and reply to emails that reduce uncertainty. They can smell a template that was also sent to 400 peers. The hook that earns a look is a problem they personally still own because the team is small. The ask should stay at this size: a yes/no on timing, or a 15-minute working chat. Delete trigger: Calling them a 'decision maker' or pitching like they're a Fortune 500 process. a problem they personally still own because the team is small

How Pharmaceuticals changes the note

Pharmaceuticals buyers are commercial, medical, and ops leads who work under review boards and long timelines. Don't invent clinical claims. Don't treat HCPs like a funnel. If you don't know the rules, your email is a liability. A credible proof point in this vertical sounds like: cut review cycles on a leave-behind by catching claims issues before legal saw the tenth draft. Watch the language. Words that land here include MLR, label, access, HCP, congress, promotional review. Launch calendars and review boards set speed. You don't. Words that work: MLR, label, access, HCP, congress, promotional review.

How should I customize this template before I send it?

Replace the pain line with an agency waiting on MLR while the sales team keeps asking 'is it approved yet'.
Keep the tone human and specific.
If they intro you, report back after the meeting.
Time it for Same day, then 3 days if silent. Same day with the recap. A value bump 3 days later if they went quiet.
Don't use consumer-startup slang. It's a credibility leak.

What mistakes should I avoid with this after demo note?

Asking 'who do you know?' is lazy and gets no names.
Don't send a 19-page deck that relitigates features they skipped.
Don't use consumer-startup slang. It's a credibility leak.
Calling them a 'decision maker' or pitching like they're a Fortune 500 process.

How does this after demo scenario compare?

Dimension	For this template
Best send window	Same day, then 3 days if silent
Ideal length	Short, vivid, one proof point max.
Primary ask	a yes/no on timing, or a 15-minute working chat
Industry metric to cite	time through MLR, access, and compliant engagement rates
Tone	Human and specific. Peer to peer, not vendor to 'target.'
Unlike after meeting	They have product context now. Speak to what they saw, not to a generic intro.
Unlike after proposal	Pricing may not be on paper yet. Don't jump to 'ready to sign.'

What should I copy and send?

Copy-ready template

Subject

Quick referral ask on [topic]

Body

Hi [First Name],

I'm looking for a warm intro to [specific role] who owns [pain], and you came to mind because [reason].

In Pharmaceuticals, that usually shows up as follow-up that ignores MLR, off-label risk, and the fact that 'just a quick claim' isn't quick. If now is a bad time, don't spend political capital on this.

Given this is after a demo, ask who else needs to see it, or whether a narrower use case is the better start.

Comfortable making that intro, or should I find another path?

Best,
[Your Name]
[Your Title]
[Your Company]

Questions people ask before they hit send

Lead with time through MLR, access, and compliant engagement rates. That's the language this buyer already reports. If you can't connect your email to follow-up that ignores MLR, off-label risk, and the fact that 'just a quick claim' isn't quick, you're asking them to do the translation work. They won't.

Related templates

Want a custom draft instead? Try the email generator.